ArticleFrontiers in oncology2026
Case Report: Glioblastoma in cohabiting partners: a molecularly characterized temporal cluster.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Glioblastoma is the most lethal primary brain tumor of adults, with an age-standardized incidence of 5-7 per 100,000 person-years and a median survival of approximately 15 months despite maximal safe resection, radiotherapy, and temozolomide. Its occurrence in two unrelated cohabiting individuals within a short interval is an uncommon event that inevitably raises the question of shared causation, one that available retrospective methods rarely resolve. Case presentation: Two unrelated adults from northern Italy, partners sharing a household since 2018 and a workplace since 2016, developed glioblastoma approximately 20 months apart. Case 1 was a 47-year-old woman with giant cell glioblastoma, IDH-wildtype, central nervous system (CNS) WHO grade 4, O Exposure assessment: A structured retrospective exposure-history questionnaire was administered to Case 2 during his diagnostic hospital admission. The assessment documented a shared office-based occupational and residential context without identifying a specific carcinogenic exposure. Multiple relevant domains, including radon, indoor air quality, household and water chemistry, remained unmeasured and should not be interpreted as negative findings. Conclusion: This report documents a temporal cluster without implying shared causation. Its primary contribution is the detailed molecular characterization of both cases, including recurrence profiling in Case 1, and a transparent, reproducible exposure-history framework that distinguishes absent from unmeasured data.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.